Ronan Lyons is a partner in A&L Goodbody's Corporate and M&A group, advising on M&A, private equity and capital markets transactions. As well as advising Irish companies, Ronan specialises in advising international companies and private equity firms on their cross-border transactions into Ireland, including public M&A. Ronan advises across a broad range of sectors, including life sciences, tech, financial services and industrials. Ronan also frequency advises on equity capital markets transactions, including in respect of NYSE and NASDAQ IPOs and fundraisings, representing issuers and underwriters. He also advises on corporate migrations / redomiciliations to Ireland.
Ronan also frequently advises US and other international companies who are establishing operations in Ireland for the first time, with a particular emphasis on the life sciences and tech sectors.
Areas of Expertise
Corporate and M&A/Private Equity/Capital Markets – Equity/Corporate migrations to Ireland and de-SPAC M&A/Investing in Ireland/Life Sciences/PLC Advisory & Governance
Experience Advising:
- K1 Investment Management on its P2P acquisition of MariaDB plc
- Inflexion Private Equity Partners on its acquisition of SteriPack
- The underwriters in Avadel Pharmaceuticals plc’s (Nasdaq: AVDL) follow-on equity offering and exchange of convertible notes and the representatives of the initial purchasers in Seagate plc’s (Nasdaq: STX), offering of $1.5bn exchangeable notes and related capped call transactions
- Crestview Partners and its portfolio company SyBridge Technologies on the acquisition of Galway Tool & Mould Ltd
- BlackRock Inc. on its equity investment into Circle Internet Financial, a global fintech firm and digital currency issuer
- Pilgrim's Pride Corporation on its $952m acquisition of Kerry Group's meats and meal business
- Xeris Pharmaceuticals Inc on its acquisition of Strongbridge Biopharma plc
- US technology company Akamai Technologies Inc. on its acquisition of Asavie Technologies
- Nabriva Therapeutics on its acquisition of Zavante Therapeutics, the redomicile of Nabriva from Austria to Ireland, its listing on NASDAQ and subsequent underwritten equity offerings
- Morgan Stanley, as AbbVie's lead financial advisor and lender, in connection with AbbVie's $63bn acquisition of Allergan
- Johnson Controls on its $20bn merger with Tyco and migration to Ireland
Market Recommendations
"Very communicative and provided clear explanations on challenges arising in documentation." (IFLR1000 2023)
"Ronan provides excellent legal and business advice." (IFLR1000 2022)
"Market Leader." (IFLR1000 2022)
"Highly professional, responsive and extremely knowledgeable." (IFLR1000 2019)
Professional activities
Ronan has been a contributor to publications on European M&A law and European securities law. He is a member of the Law Society of Ireland and the Dublin Solicitors Bar Association.
Education
- Solicitor, Law Society of Ireland
- BCL, University College Cork
Ronan Lyons
Partner,
Corporate and M&A
Dublin